semaglutide içeren ilaçlar Rybelsus (Semaglutide Tablets) in Canada for Diabetes Management Obezite Tedavisinde Yeni Bir Dönem:

[DOI] [PubMed] [Google Scholar] Evans W.J., Morley J.E., Argils J., Bales C., Baracos V., Guttridge D., Jatoi A., Kalantar-Zadeh K., Lochs H., Mantovani G., Marks D., Mitch W.E., Muscaritoli M., Najand A., Ponikowski P., Rossi Fanelli F., Schambelan M., Schols A., Schuster M., Thomas D., Wolfe R., Anker S.D

doi: 10.1080/15592294.2018.1486654

Retrieved 28 September 2025

Leerink Partners analyst David Risinger characterized the results as "best-in-class weight loss" data, while RBC Capital Markets analyst Trung Huynh wrote that the pill looks like "another potential oral option to the market that will be competing for share in the future" with Novo's Wegovy pill and Lilly's orforglipron, the latter of which could be cleared in the U.S